Aptose Biosciences Inc. - Common Shares

CUSIP: 03835T200

Q3 2017 13F Holders as of 30 Sep 2017

Holder snapshot 6 signals
Share change
-915,119
SEC-reported price per share
$1.48
Indexed holders
11
Value change
-$1,105,838
Number of buys
4
Number of sells
5
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
2,556,332

Security key

03835T200

Report period

Q3 2017

Indexed institutions

11

Top holders

9

Ownership snapshot

Top reported holders of 03835T200 - Aptose Biosciences Inc. - Common Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Cormorant Asset Managemen...
Disclosed value leader
Cormorant Asset Managemen...
Comparable rows
0/9
Latest evidence
30 Jun 2017
13F Highest disclosed value: $1,218,000 9 rows are not safely comparable across share classes. Showing 1-6 of 9 holder rows.

Quick read

Cormorant Asset Management, LP has the largest disclosed position value at $1.22M.

0 of 9 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Cormorant Asset Management, LP's linked filing trail.
Disclosed position value Top 5
Cormorant Asset Management, LP $1.22M
RENAISSANCE TECHNOLOGIES LLC $39K
ROYAL BANK OF CANADA $36K
BANK OF MONTREAL /CAN/ $23K
Federation Des Caisses Desjardins... $11.6K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 9 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Cormorant Asset Management, LP
13F
Company
13F
—
denominator unverified
$1,218,000
990,579 shares
— 30 Jun 2017
RENAISSANCE TECHNOLOGIES LLC
13F
Company
13F
—
denominator unverified
$39,000
31,200 shares
— 30 Jun 2017
ROYAL BANK OF CANADA
13F
Company
13F
—
denominator unverified
$36,000
29,861 shares
— 30 Jun 2017
BANK OF MONTREAL /CAN/
13F
Company
13F
—
denominator unverified
$23,000
18,336 shares
— 30 Jun 2017
Federation Des Caisses Desjardins du Quebec
13F
Individual
13F
—
denominator unverified
$11,627
9,554 shares
— 30 Jun 2017
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$7,000
5,432 shares
— 30 Jun 2017
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2017

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
11
Shares
177,400
Indexed holders
11
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q3 2017 vs Q2 2017 Across Filers

Q2 2017 indexed holders
7
Q3 2017 indexed holders
11
Indexed holder difference
4
Investor Q2 2017 Shares Q3 2017 Shares Share Diff Share Chg % Q2 2017 value Q3 2017 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .